Camila (norethindrone 0.35 mg) Dailymed

Progestin-only oral contraceptives are indicated for the prevention of pregnancy.

If used perfectly, the first-year failure rate for progestin-only oral contraceptives is 0.5%. However, the typical failure rate is estimated to be closer to 5%, due to late or omitted pills. The following table lists the pregnancy rates for users of all major methods of contraception.

If used perfectly, the first-year failure rate for progestin-only oral contraceptives is 0.5%. However, the typical failure rate is estimated to be closer to 5%, due to late or omitted pills. The following table uls the pregnancy rates for users of all major methods of contraception. Table 2: Percentage of Women Experiencing an Unintended Pregnancy During the First Year of Typical Use and the First Year of Perfect Use of Contraception and the Percentage Continuing Use at the End of the First Year. United States.    % of Women Experiencing an Unintended Pregnancy within the First Year of Use  % of Women Continuing Use at One Year3  Method (1)  Typical Use1 (2)  Perfect Use2 (3) (4)  Chance4  85  85    Spermicides5  26  6  40  Periodic Abstinence  25    63     Calendar    9       Ovulation Method    3       Sympto-Thermal6    2       Post-Ovulation    1    Cap7           Parous Women  40  26  42     Nulliparous Women  20  9  56  Sponge           Parous Women  40  20  42     Nulliparous Women  20  9  56  Diaphragm7  20  6  56  Withdrawal  19  4    Condom8           Female (Reality)  21  5  56     Male  14  3  61  Pill  5    71     Progestin-only    0.5       Combined    0.1    IUDs           Progesterone T  2  1.5  81     Copper T380A  0.8  0.6  78     LNg 20  0.1  0.1  81  Depo-Provera  0.3  0.3  70  Levonorgestrel Implants   (Norplant)  0.05  0.05  88  Female Sterilization  0.5  0.5  100  Male Sterilization  0.15  0.10  100 Emergency Contraceptive Pills: Treatment initiated within 72 hours after unprotected intercourse reduces the risk of pregnancy by at least 75%.9 Lactational Amenorrhea Method: LAM is a highly effective, temporary method of contraception.10 Source: Trussell, J, Contraceptive Efficacy. In: Hatcher RA, Trussell J, Stewart F, Cates W, Stewart GK, Kowal D, Guest F, Contraceptive Technology: Seventeenth Revised Edition. New York NY: Irvington Publishers, 1998. 1 Among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any reason. 2 Among couples who initiate use of a method (not necessarily for the first time), and who use it perfectly (both consistently and correctly), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason. 3 Among couples attempting to avoid pregnancy, the percentage who continue to use a method for one year. 4 The percentage of women becoming pregnant noted in columns (2) and (3) are based on data from populations where contraception is not used and from women who cease using contraception in order to become pregnant. Among such populations, about 89% become pregnant within one year. This estimate was lowered slightly (to 85%) to represent the percentage that would become pregnant within one year among women now relying on reversible methods of contraception if they abandoned contraception altogether. 5 Foams, creams, gels, vaginal suppositories, and vaginal film. 6 Cervical mucus (ovulation) method supplemented by calendar in the pre-ovulatory and basal body temperature in the post-ovulatory phases. 7 With spermicidal cream or jelly. 8 Without spermicides. 9 The treatment schedule is one dose within 72 hours after unprotected intercourse, and a second dose 12 hours after the first dose. The Food and Drug Administration has declared the following brands of oral contraceptives to be safe and effective for emergency contraception: Ovral (1 dose is 2 white pills), Alesse (1 dose is 5 pink pills), Nordette or Levlen (1 dose is 4 yellow pills). 10 However, to maintain effective protection against pregnancy, another method of contraception must be used as soon as menstruation resumes, the frequency or duration of breastfeeds is reduced, bottle feeds are introduced, or the baby reaches 6 months of age.

The incidence of ectopic pregnancies for progestin-only oral contraceptive users is 5 per 1000 woman-years. Up to 10% of pregnancies reported in clinical studies of progestin-only oral contraceptive users are extrauterine. Although symptoms of ectopic pregnancy should be watched for, a history of ectopic pregnancy need not be considered a contraindication to use of this contraceptive method. Health providers should be alert to the possibility of an ectopic pregnancy in women who become pregnant or complain of lower abdominal pain while on progestin-only oral contraceptives.

Irregular menstrual patterns are common among women using progestin-only oral contraceptives. If genital bleeding is suggestive of infection, malignancy or other abnormal conditions, such nonpharmacologic causes should be ruled out. If prolonged amenorrhea occurs, the possibility of pregnancy should be evaluated.

Contraceptive effectiveness may be reduced when hormonal contraceptives are coadministered with antibiotics, anticonvulsants, and other drugs that increase the metabolism of contraceptive steroids. This could result in unintended pregnancy or breakthrough bleeding. Examples include rifampin, barbiturates, phenylbutazone, phenytoin, carbamazepine, felbamate, oxcarbazepine, topiramate, and griseofulvin.

Many studies have found no effects on fetal development associated with long-term use of contraceptive doses of oral progestins. The few studies of infant growth and development that have been conducted have not demonstrated significant adverse effects. It is nonetheless prudent to rule out suspected pregnancy before initiating any hormonal contraceptive use.

Small amounts of progestin pass into the breast milk, resulting in steroid levels in infant plasma of 1 to 6% of the levels of maternal plasma. However, isolated post-market cases of decreased milk production have been reported in POPs. Very rarely, adverse effects in the infant/child have been reported, including jaundice.

HOW DO POPS WORK? •They make the cervical mucus at the entrance to the womb (the uterus) too thick for the sperm to get through to the egg. •They prevent ovulation (release of the egg from the ovary) in about half the time. •They also affect other hormones, the fallopian tubes and the lining of the uterus. YOU SHOULD NOT TAKE POPS •If there is any chance you may be pregnant. •If you have breast cancer. •If you have bleeding between your periods which has not been diagnosed. •If you are taking certain drugs for epilepsy (seizures) or for TB. (See USING POPS WITH OTHER MEDICINES below.) •If you are hypersensitive or allergic to any component of this product. •If you have liver tumors, either benign or cancerous. •If you have acute liver disease. RISKS OF TAKING POPS WARNING: If you have sudden or severe pain in your lower abdomen or stomach area, you may have an ectopic pregnancy or an ovarian cyst. If this happens, you should contact your doctor or clinic immediately. 1. Ectopic Pregnancy An ectopic pregnancy is a pregnancy outside the womb. Because POPs protect against pregnancy, the chance of having pregnancy outside the womb is very low. If you do get pregnant while taking POPs, you have a slightly higher chance that the pregnancy will be ectopic than do users of some other birth control methods. 2. Ovarian Cysts These cysts are small sacs of fluid in the ovary. They are more common among POP users than among users of most other birth control methods. They usually disappear without treatment and rarely cause problems. 3. Cancer of the Reproductive Organs and Breasts Some studies in women who use combined oral contraceptives that contain both estrogen and a progestin have reported an increase in the risk of developing breast cancer, particularly at a younger age and apparently related to duration of use. There is insufficient data to determine whether the use of POPs similarly increases this risk. Some studies have found an increase in the incidence of cancer of the cervix in women who use oral contraceptives. However, this finding may be related to factors other than the use of oral contraceptives and there is insufficient data to determine whether the use of POPs increases the risk of developing cancer of the cervix. 4. Liver Tumors In rare cases, combined oral contraceptives can cause benign but dangerous liver tumors. These benign liver tumors can rupture and cause fatal internal bleeding. In addition, a possible but not definite association has been found with combined oral contraceptives and liver cancers in studies in which a few women who developed these very rare cancers were found to have used combined oral contraceptives for long periods of time. There is insufficient data to determine whether POPs increase the risk of liver tumors. SEXUALLY TRANSMITTED DISEASES (STDS) WARNING: POPs do not protect against getting or giving someone HIV (AIDS) or any other STD, such as Chlamydia, gonorrhea, genital warts or herpes. SIDE EFFECTS 1. Irregular Bleeding The most common side effect of POPs is a change in menstrual bleeding. Your periods may be either early or late, and you may have some spotting between periods. Taking pills late or missing pills can also result in some spotting or bleeding. 2. Other Side Effects Less common side effects include headaches, tender breasts, nausea and dizziness. Weight gain, acne and extra hair on your face and body have been reported, but are rare. If you are concerned about any of these side effects, check with your doctor or clinic. USING POPS WITH OTHER MEDICINES Before taking a POP, inform your health care provider of any other medication, including over-the-counter medicine, that you may be taking. If you are taking medicines for seizures (epilepsy) or tuberculosis (TB), tell your doctor or clinic. These medicines can make POPs less effective: Medicines for seizures: •Phenytoin (Dilantin) •Carbamazepine (Tegretol) •Phenobarbital Medicine for TB: •Rifampin (Rifampicin) Before you begin taking any new medicines be sure your doctor or clinic knows you are taking birth control pills that contain a progestin. HOW TO TAKE POPS   IMPORTANT POINTS TO REMEMBER •POPs must be taken at the same time every day, so choose a time and then take the pill at the same time every day. Every time you take a pill late, and especially if you miss a pill, you are more likely to get pregnant. •Start the next pack the day after the last pack is finished. There is no break between packs. Always have your next pack of pills ready. •You may have some menstrual spotting between periods. Do not stop taking your pills if this happens. •If you vomit soon after taking a pill, use a backup method (such as condom and/or spermicide) for 48 hours. •If you want to stop taking POPs, you can do so at any time, but, if you remain sexually active and don't wish to become pregnant, be certain to use another birth control method. •If you are not sure about how to take POPs, ask your doctor or clinic. STARTING POPS •It's best to take your first POP on the first day of your menstrual period. •If you decide to take your first POP on another day, use a backup method (such as condom and/or spermicide) every time you have sex during the next 48 hours. •If you have had a miscarriage or an abortion, you can start POPs the next day. IF YOU ARE LATE OR MISS TAKING YOUR POPS •If you are more than 3 hours late or you miss one or more POPs: 1.TAKE a missed pill as soon as you remember that you missed it, 2.THEN go back to taking POPs at your regular time, 3.BUT be sure to use a backup method (such as condom and/or spermicide) every time you have sex for the next 48 hours. •If you are not sure what to do about the pills you have missed, keep taking POPs and use a backup method until you can talk to your doctor or clinic. IF YOU ARE BREASTFEEDING •If you are fully breastfeeding (not giving your baby any food or formula), you may start your pills 6 weeks after delivery. •If you are partially breastfeeding (giving your baby some food or formula), you should start taking pills by 3 weeks after delivery. IF YOU ARE SWITCHING PILLS •If you are switching from the combined pills to POPs, take the first POP the day after you finish the last active combined pill. Do not take any of the 7 inactive pills from the combined pill pack. You should know that many women have irregular periods after switching to POPs, but this is normal and to be expected. •If you are switching from POPs to the combined pills, take the first active combined pill on the first day of your period, even if your POPs pack is not finished. •If you switch to another brand of POPs, start the new brand anytime. •If you are breastfeeding, you can switch to another method of birth control at any time, except do not switch to the combined pills until you stop breastfeeding or at least until 6 months after delivery. PREGNANCY WHILE ON THE PILL If you become pregnant, or think you might be, stop taking POPs and contact your physician. Even though research has shown that POPs do not cause harm to the unborn baby, it is always best not to take any drugs or medicines that you don't need when you are pregnant. You should get a pregnancy test: •If your period is late and you took one or more pills late or missed taking them and had sex without a backup method. •Anytime you miss 2 periods in a row. WILL POPS AFFECT YOUR ABILITY TO GET PREGNANT LATER? If you want to become pregnant, simply stop taking POPs. POPs will not delay your ability to get pregnant. BREASTFEEDING If you are breastfeeding, POPs will not affect the quality or amount of your breast milk or the health of your nursing baby. However, isolated cases of decreased milk production have been reported. If you suspect that you are not producing enough milk for your baby, contact your doctor or clinic. OVERDOSE No serious problems have been reported when many pills were taken by accident, even by a small child, so there is usually no reason to treat an overdose. OTHER QUESTIONS OR CONCERNS Cigarette smoking greatly increases the possibility of suffering heart attacks and strokes. Women who use oral contraceptives are strongly advised not to smoke. Diabetic women taking POPs do not generally require changes in the amount of insulin they are taking. However, your physician may monitor you more closely under these conditions. If you have any questions or concerns, check with your doctor or clinic. You can also ask for the more detailed "professional package labeling" written for doctors and other health care providers. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. HOW TO STORE YOUR POPS Store your POPs at room temperature 20 to 25°C (68 to 77°F). INSTRUCTIONS TO PATIENTS How to Use the Camila Tablets Buler Card 1. The first time you use these pills, take your first pill on the first day of your menstrual period. Pick the Days of the Week Sticker that starts the first day of your period. When you have picked the right sticker, throw away the others and place the sticker on the buler card over the pre-printed days of the week and make sure it lines up with the pills. 2. Your buler package consists of three parts, the foil pouch, wallet, and a buler card containing 28 individually sealed pills. Note that the pills are arranged in four numbered rows of 7 pills, with the pre-printed days of the week printed above them. All 28 pills are “active” birth control pills. Refer to the sample of the buler card below: 3. To remove a pill, push down on the pill with your thumb and forefinger so that the pill releases through the back of the buler card. Each day, take one pill. Always go from left to right along the row. Each new row will begin on the same day of the week. 4. Take one pill every day for 28 days, whether bleeding or not, until you have taken all the pills. It is important that you take your pill at the same time every day. 5. After you have taken all 28 pills, begin taking your pills again the next day. Be sure that the calendar day on your new package corresponds with the actual day. All brand names uled are the registered trademarks of their respective owners and are not trademarks of Teva Pharmaceuticals USA. TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Rev. A 10/2015